157 related articles for article (PubMed ID: 18226007)
1. Nephrogenic systemic fibrosis: a sufficient reason to avoid gadolinium-based contrast in all patients with renal impairment?
Willicombe M; Cunningham J
Semin Dial; 2008; 21(2):140-1. PubMed ID: 18226007
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney disease.
Perazella MA; Reilly RF
Semin Dial; 2008; 21(2):171-3. PubMed ID: 18226005
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
4. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
Grobner T; Prischl FC
Semin Dial; 2008; 21(2):135-9. PubMed ID: 18226001
[TBL] [Abstract][Full Text] [Related]
5. Dialytic therapies to prevent NSF following gadolinium exposure in high-risk patients.
Rodby RA
Semin Dial; 2008; 21(2):145-9. PubMed ID: 18226002
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic systemic fibrosis and gadolinium-based contrast: medico-legal implications.
Houck CM; Pristave RJ; Kannensohn KJ
Semin Dial; 2008; 21(2):166-70. PubMed ID: 18226003
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
Peak AS; Sheller A
Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic systemic fibrosis].
Breitschaft A; Stahlmann R
Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium and nephrogenic systemic fibrosis: association or causation.
Kurtkoti J; Snow T; Hiremagalur B
Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents?
Penfield JG; Reilly RF
Semin Dial; 2008; 21(2):129-34. PubMed ID: 18225999
[TBL] [Abstract][Full Text] [Related]
11. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
Thomsen HS
Radiol Clin North Am; 2009 Sep; 47(5):871-5, vii. PubMed ID: 19744601
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis and gadolinium-based contrast: what's a nephrologist to do?
Perazella MA
Semin Dial; 2008; 21(2):121-2. PubMed ID: 18248521
[No Abstract] [Full Text] [Related]
13. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
Heinrich M; Uder M
Rofo; 2007 Jun; 179(6):613-7. PubMed ID: 17497597
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic systemic fibrosis: a nephrologist's perspective.
Saab G; Cheng S
Hemodial Int; 2007 Oct; 11 Suppl 3():S2-6. PubMed ID: 17897106
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic systemic fibrosis: non-gadolinium options for the imaging of CKD/ESRD patients.
Dawson P; Punwani S
Semin Dial; 2008; 21(2):160-5. PubMed ID: 18226006
[TBL] [Abstract][Full Text] [Related]
16. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
17. Current status of gadolinium toxicity in patients with kidney disease.
Perazella MA
Clin J Am Soc Nephrol; 2009 Feb; 4(2):461-9. PubMed ID: 19201920
[TBL] [Abstract][Full Text] [Related]
18. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
van der Meij N; Keur I; van Lienden KP; Scheepstra CG; Bos JD
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2898-903. PubMed ID: 18257437
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency.
Chewning RH; Murphy KJ
J Vasc Interv Radiol; 2007 Mar; 18(3):331-3. PubMed ID: 17377176
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis: a report of 29 cases.
Shabana WM; Cohan RH; Ellis JH; Hussain HK; Francis IR; Su LD; Mukherji SK; Swartz RD
AJR Am J Roentgenol; 2008 Mar; 190(3):736-41. PubMed ID: 18287446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
